T1	Eq-Comparison 42 65	day -10 pre- to day +30
E1	Eq-Comparison:T1 Value:T61 Operator:T2 Temporal-Unit:T90
T3	Temporal-Connection 66 70	post
E3	Temporal-Connection:T3 Arg:E1 Arg2:E4
A1	Temporal-Connection-Type-Value E3 after
T4	Procedure 71 111	allogeneic hematopoietic cell transplant
E4	Procedure:T4 Name:T94
T5	Procedure 113 117	AHCT
E5	Procedure:T5 Name:T95
T6	Modifier 128 133	donor
E6	Modifier:T6 Modifies:T95
T7	Or 134 136	or
E7	Or:T7 Arg:E6 Arg2:E8
T8	Modifier 137 149	graft source
E8	Modifier:T8 Modifies:T95
T9	And 150 153	and
E9	And:T9 Arg:E5 Arg2:E10
T10	Procedure 162 182	conditioning regimen
E10	Procedure:T10 Name:T96
T11	Eq-Comparison 206 214	received
E11	Eq-Comparison:T11 Temporal-Period:T97
T12	Procedure 215 224	treatment
E12	Procedure:T12 Temporality:E11 Duration:E20 Temporality2:E21
T13	Drug 230 239	meropenem
E13	Drug:T13 Name:T98
T14	Or 240 242	or
E14	Or:T14 Arg:E13 Arg2:E16
T16	Drug 243 266	piperacillin-tazobactam
E16	Drug:T16 Name:T99
T17	Drug 268 276	pip-tazo
E17	Drug:T17 Name:T100
T19	Modifier 293 295	IV
E19	Modifier:T19 
T20	Eq-Comparison 301 327	at least 24 hours duration
E20	Eq-Comparison:T20 Operator:T102 Value:T103 Temporal-Unit:T104
T21	Eq-Comparison 332 343	past 7 days
E21	Eq-Comparison:T21 Temporal-Period:T105 Value:T106 Temporal-Unit:T107
T22	Modifier 349 359	Controlled
E22	Modifier:T22 Modifies:T108
T23	Condition 360 369	infection
E23	Condition:T23 Name:T108
T24	Condition 381 396	hemodynamically
E24	Condition:T24 Name:T18 Stability:T109
T25	And 404 407	and
E25	And:T25 Arg:E26
T26	Negation 408 411	not
E26	Negation:T26 Negates:E27
T27	Assertion 412 421	requiring
E27	Assertion:T27 Asserted:E28
A2	Assertion-Type-Value E27 hypothetical
T28	Procedure 422 441	supplemental oxygen
E28	Procedure:T28 Name:T92
T29	Eq-Comparison 445 467	more than 2 liters via
E29	Eq-Comparison:T29 Operator:T110 Value:T111 Unit:T112
T31	Assertion 504 511	able to
E31	Assertion:T31 Asserted:E32
A3	Assertion-Type-Value E31 hypothetical
T32	Drug 517 533	oral medications
E32	Drug:T32 Name:T114
T33	Assertion 703 717	anticipated to
E33	Assertion:T33 Asserted:E34
A4	Assertion-Type-Value E33 hypothetical
T34	Drug 751 762	antibiotics
E34	Drug:T34 Name:T115
T35	Drug 768 777	meropenem
E35	Drug:T35 Name:T116
T36	Or 778 780	or
E36	Or:T36 Arg:E35 Arg2:E37
T37	Drug 781 789	pip-tazo
E37	Drug:T37 Name:T117 Duration:E39
T39	Eq-Comparison 797 807	> 96 hours
E39	Eq-Comparison:T39 Operator:T118 Value:T119 Temporal-Unit:T120
T40	Temporal-Connection 808 812	post
E40	Temporal-Connection:T40 Arg:E37 Arg2:E91
A5	Temporal-Connection-Type-Value E40 after
T41	Condition 855 865	infections
E41	Condition:T41 Name:T122
T42	Assertion 866 879	necessitating
E42	Assertion:T42 Asserted:E43
A6	Assertion-Type-Value E42 hypothetical
T43	Procedure 890 899	treatment
E43	Procedure:T43 
T44	Eq-Comparison 921 926	prior
E44	Eq-Comparison:T44 Temporal-Period:T123
T45	Condition 938 947	infection
E45	Condition:T45 Name:T124 Temporality:E44
T47	Eq-Comparison 988 1007	greater than 2 days
E47	Eq-Comparison:T47 Operator:T126 Value:T127 Temporal-Unit:T128
T48	Temporal-Connection 1008 1012	from
E48	Temporal-Connection:T48 Arg:E47 Arg2:E49
A7	Temporal-Connection-Type-Value E48 after
T51	Temporal-Connection 1044 1048	post
E51	Temporal-Connection:T51 Arg:E49 Arg2:E52
A8	Temporal-Connection-Type-Value E51 after
T52	Procedure 1049 1053	AHCT
E52	Procedure:T52 Name:T49
T53	Eq-Comparison 1073 1079	active
E53	Eq-Comparison:T53 Temporal-Period:T130
T54	Modifier 1080 1087	enteric
E54	Modifier:T54 Modifies:T131
T55	Condition 1088 1098	infections
E55	Condition:T55 Name:T131 Temporality:E53
T56	Condition 1124 1128	GVHD
E56	Condition:T56 Name:T133 Stage:E57 Severity:T132
T57	Eq-Comparison 1129 1140	>= grade II
E57	Eq-Comparison:T57 Operator:T134 Unit:T135 Value:T136
T58	Assertion 1155 1164	unwilling
E58	Assertion:T58 Asserted:E61
A9	Assertion-Type-Value E58 hypothetical
T59	Or 1165 1167	or
E59	Or:T59 Arg:E58 Arg2:E60
T60	Assertion 1168 1174	unable
E60	Assertion:T60 Asserted:E88
A10	Assertion-Type-Value E60 hypothetical
T62	Procedure 1190 1193	FMT
E61	Procedure:T62 Name:T137
T63	Procedure 1198 1223	retention enema procedure
E62	Procedure:T63 Name:T138
T64	Eq-Comparison 1247 1255	received
E63	Eq-Comparison:T64 Temporal-Period:T139
T65	Procedure 1256 1265	treatment
E64	Procedure:T65 Temporality:E63 Temporality2:E67
T66	Study 1274 1289	investigational
E65	Study:T66 Study-Of:E66
T67	Drug 1290 1295	agent
E66	Drug:T67 
T68	Eq-Comparison 1296 1310	within 2 weeks
E67	Eq-Comparison:T68 Operator:T140 Value:T141 Temporal-Unit:T142
T69	Temporal-Connection 1311 1313	of
E68	Temporal-Connection:T69 Arg:E67 Arg2:E69
A11	Temporal-Connection-Type-Value E68 before
T70	Study 1314 1324	enrollment
E69	Study:T70 
T71	Negation 1339 1357	unable to tolerate
E70	Negation:T71 Negates:E71
T72	Procedure 1358 1378	oral decontamination
E71	Procedure:T72 Name:T143
T73	Drug 1390 1398	pip-tazo
E72	Drug:T73 Name:T144
T74	Or 1399 1402	and
E73	Or:T74 Arg:E72 Arg2:E74
T75	Drug 1403 1411	nystatin
E74	Drug:T75 Name:T145
T76	Eq-Comparison 1419 1424	prior
E75	Eq-Comparison:T76 Temporal-Period:T146
T77	Allergy 1425 1432	allergy
E76	Allergy:T77 Temporality:E75 Name:E79
T78	Or 1433 1435	or
E77	Or:T78 Arg:E76 Arg2:E78
T79	Condition 1436 1447	intolerance
E78	Condition:T79 Name:T147
T81	Modifier 1492 1499	medical
E80	Modifier:T81 Modifies:E83
T82	Or 1500 1502	or
E81	Or:T82 Arg:E80 Arg2:E82
T83	Modifier 1503 1516	psychological
E82	Modifier:T83 Modifies:E83
T84	Condition 1517 1526	condition
E83	Condition:T84 
T85	Assertion 1569 1574	might
E84	Assertion:T85 Asserted:T148
A12	Assertion-Type-Value E84 hypothetical
T86	Study 1625 1630	trial
E85	Study:T86 Stability:T148
T88	Risk 1652 1656	risk
E87	Risk:T88 
T89	Negation 1168 1174	unable
E88	Negation:T89 Negates:E61
T90	Eq-Temporal-Unit 42 45	day
A13	Eq-Temporal-Unit-Value T90 day
T91	Eq-Temporal-Unit 58 61	day
A14	Eq-Temporal-Unit-Value T91 day
T93	Eq-Value 63 65	30
T94	Procedure-Name 71 111	allogeneic hematopoietic cell transplant
T95	Procedure-Name 113 117	AHCT
T96	Procedure-Name 162 182	conditioning regimen
T97	Eq-Temporal-Period 206 214	received
A16	Eq-Temporal-Period-Value T97 past
T98	Drug-Name 230 239	meropenem
T99	Drug-Name 243 266	piperacillin-tazobactam
T100	Drug-Name 268 276	pip-tazo
T102	Eq-Operator 301 309	at least
A17	Eq-Operator-Value T102 GTEQ
T103	Eq-Value 310 312	24
T104	Eq-Temporal-Unit 313 318	hours
A18	Eq-Temporal-Unit-Value T104 hour
T105	Eq-Temporal-Period 332 336	past
A19	Eq-Temporal-Period-Value T105 past
T106	Eq-Value 337 338	7
T107	Eq-Temporal-Unit 339 343	days
A20	Eq-Temporal-Unit-Value T107 day
T108	Condition-Name 360 369	infection
T109	Stability 397 403	stable
A21	Stability-Value T109 stable
T110	Eq-Operator 445 454	more than
A22	Eq-Operator-Value T110 GT
T111	Eq-Value 455 456	2
T112	Eq-Unit 457 463	liters
T114	Drug-Name 517 533	oral medications
T115	Drug-Name 751 762	antibiotics
T116	Drug-Name 768 777	meropenem
T117	Drug-Name 781 789	pip-tazo
T118	Eq-Operator 797 798	>
A23	Eq-Operator-Value T118 GT
T119	Eq-Value 799 801	96
T120	Eq-Temporal-Unit 802 807	hours
A24	Eq-Temporal-Unit-Value T120 hour
T121	Procedure-Name 813 824	engraftment
T122	Condition-Name 855 865	infections
T123	Eq-Temporal-Period 921 926	prior
A25	Eq-Temporal-Period-Value T123 past
T124	Condition-Name 938 947	infection
T126	Eq-Operator 988 1000	greater than
A26	Eq-Operator-Value T126 GT
T127	Eq-Value 1001 1002	2
T128	Eq-Temporal-Unit 1003 1007	days
A27	Eq-Temporal-Unit-Value T128 day
T130	Eq-Temporal-Period 1073 1079	active
A28	Eq-Temporal-Period-Value T130 present
T131	Condition-Name 1088 1098	infections
T132	Severity 1118 1123	acute
A29	Severity-Value T132 severe
T133	Condition-Name 1124 1128	GVHD
T134	Eq-Operator 1129 1131	>=
A30	Eq-Operator-Value T134 GTEQ
T135	Eq-Unit 1132 1137	grade
T136	Eq-Value 1138 1140	II
T137	Procedure-Name 1190 1193	FMT
T138	Procedure-Name 1198 1223	retention enema procedure
T139	Eq-Temporal-Period 1247 1255	received
A31	Eq-Temporal-Period-Value T139 past
T140	Eq-Operator 1296 1302	within
A32	Eq-Operator-Value T140 LTEQ
T141	Eq-Value 1303 1304	2
T142	Eq-Temporal-Unit 1305 1310	weeks
A33	Eq-Temporal-Unit-Value T142 week
T143	Procedure-Name 1358 1378	oral decontamination
T144	Drug-Name 1390 1398	pip-tazo
T145	Drug-Name 1403 1411	nystatin
T146	Eq-Temporal-Period 1419 1424	prior
A34	Eq-Temporal-Period-Value T146 past
T147	Condition-Name 1436 1447	intolerance
T148	Stability 1575 1584	interfere
A35	Stability-Value T148 change
T149	Stability 1677 1685	confound
A36	Stability-Value T149 change
T61	Eq-Value 46 49	-10
T2	Eq-Operator 55 57	to
A15	Eq-Operator-Value T2 BETWEEN
R1	Abbrev-Of Arg1:E5 Arg2:E4	
R2	Using Arg1:E12 Arg2:E13	
R3	Abbrev-Of Arg1:E17 Arg2:E16	
T15	Modifier 278 291	intravenously
E2	Modifier:T15 Modifies:T100
R4	Abbrev-Of Arg1:E19 Arg2:E2	
R5	Using Arg1:E12 Arg2:E16	
T18	Condition-Name 381 396	hemodynamically
R6	Equivalent-To Arg1:E24 Arg2:E23	
T92	Procedure-Name 422 441	supplemental oxygen
T30	Modifier 468 481	nasal cannula
E15	Modifier:T30 Modifies:T92
T101	Observation 422 441	supplemental oxygen
E18	Observation:T101 Eq-Comparison:E29
T113	Modifier 537 552	suspension form
E30	Modifier:T113 Modifies:T114
T150	Modifier 736 750	broad spectrum
E89	Modifier:T150 Modifies:T115
T151	And 763 767	with
E90	And:T151 Arg:E34 Arg2:E35
T38	Modifier 790 792	IV
E38	Modifier:T38 Modifies:T117
T152	Procedure 813 824	engraftment
E91	Procedure:T152 Name:T121
R7	Treatment-For Arg1:E43 Arg2:E41	
R8	Treatment-For Arg1:E34 Arg2:E41	
T46	Organism 953 965	mycormycetes
E46	Organism:T46 Name:T125
T125	Organism-Name 953 965	mycormycetes
R9	Caused-By Arg1:E45 Arg2:E46	
T49	Procedure-Name 1049 1053	AHCT
T50	Procedure 1021 1043	neutrophil engraftment
E49	Procedure:T50 Name:T129
T129	Procedure-Name 1021 1043	neutrophil engraftment
R10	Using Arg1:E61 Arg2:E62	
R11	Using Arg1:E64 Arg2:E66	
T153	Assertion 1339 1357	unable to tolerate
E50	Assertion:T153 Asserted:E70
A37	Assertion-Type-Value E50 hypothetical
R12	Using Arg1:E71 Arg2:E72	
T80	Coreference 1451 1468	these medications
E79	Coreference:T80 Refers-To:E74 Refers-To2:E72
R13	Caused-By Arg1:E78 Arg2:E79	
R14	Caused-By Arg1:E70 Arg2:E76	
R15	Caused-By Arg1:T148 Arg2:E83	
R16	Caused-By Arg1:E87 Arg2:E83	
T87	Or 1674 1676	or
E86	Or:T87 Arg:E87 Arg2:T149
R17	Caused-By Arg1:T149 Arg2:E83	
